Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+0.42%
-0.09%
-2.69%
MRNA
Moderna
$24.86
Chart
25.64
33.9
47.53
147.82
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.42%
-0.09%
-2.69%
MRNA
Moderna
Current Price
$24.86
Login to view Moderna (MRNA) recommendation from the last 90 days from financial news and social media.
Chart
25.64
33.9
47.53
147.82
MRNA Latest Headlines
Friday Sector Leaders: Healthcare Utilities. In afternoon trading on Friday Healthcare stocks are the best performing sector higher by 1.3%. Within that group Moderna Inc (Symbol: MRNA) and Eli Lilly (Symbol: LLY) are two large stocks leading the way showing a gain of 6.4% and 3.5% respectively. Among healthcare ETFs
Today
Modernas Options Frenzy: What You Need to Know. Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna (NASDAQ:) revealed 16 unusual trades.Delving into the details we found 18% of traders were ish while 62% showed bearish tendencies. Out of all the trades we spotted 8 were puts with a value of $507879 and 8 were calls valued at $487864.After evaluating the trading volumes and Open Interest it'.s evident that the major market movers are
Today
Wednesday Sector Laggards: Healthcare Materials. Looking at the sectors faring worst as of midday Wednesday shares of Healthcare companies are underperforming other sectors showing a 1.8% loss. Within that group Bio-Techne Corp (Symbol: TECH) and Moderna Inc (Symbol: MRNA) are two large stocks that are lagging showing a lo
Wed May 14, 2025
CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update. - Announced Positive Interim Data From Ongoing Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) in Patients with Advanced Colorectal Cancer (CRC) -- Initiated CX-2051 Phase 1 dose expansions at 7.2 mg/kg 8.6 mg/kg and 10 mg/kg doses. Additional CX-2051 Phase 1 data update expected by Q1 2026 - - Planning CX-2051 Phase 2 study initiation in 1H 2026 -- CX-801 (PROBODY®. Inte
Mon May 12, 2025
Moderna Inc. (MRNA): Among Billionaire David E. Shaws Small-Cap Stock Picks with Huge Upside Potential.
Sat May 10, 2025
Moderna Stock: Analyst Estimates & Ratings. As Moderna has significantly lagged behind the broader market over the past year Wall Street analysts maintain a cautious outlook on the stocks prospects.
Thu May 8, 2025
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026. ) reported on Thursday a first-quarter EPS loss of $(2.52) missing down from an EPS loss of $(3.07) a year ago.The COVID-19 vaccine maker reported quarterly sales of $108 million down from $167 billion a year ago beating the.The decline was primarily driven by lower net product sales which totaled $86 million in the quarter.The reduction in product sales reflects lower vaccinat
Thu May 1, 2025
Moderna: Regulatory Hurdles And Market Challenges Prompt Downgrade To Sell.
Thu May 1, 2025
Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline. Moderna stock crumbled Thursday after the biotech company missed sales estimates for its two products Spikevax and mResvia.The post Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline appeared first on Investor'.s Business Daily.
Thu May 1, 2025
Moderna says FDA has been constructive but delays flu/COVID shot.
Thu May 1, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MRNA Stock trends
MRNA Stock performance
MRNA Stock analysis
MRNA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Hover over the category for more information
